Gary Giampetruzzi, global chair of Paul Hastings’ Life Sciences practice, and Joy Dowdle, vice-chair of Paul Hastings' Life Sciences practice, are speaking at the upcoming FCPA & Anti-Corruption for the Life Sciences Industry conference in New York, NY on May 10-11, 2023.

Joy is moderating the “Life Sciences Sector Considerations for Measuring the Effectiveness of Compliance Programs: Real-World Takeaways for Updating Your Program Amid the Latest DOJ Guidance and Enforcement Posture” panel discussion on May 10 from 12:00 – 1:00 p.m. The panel will also include Terri Segura, vice president of global compliance investigations at Zimmer Biomet, and Arunabha Bhoumik, executive director and assistant general counsel at Regeneron Pharmaceuticals.

Gary will moderate a panel discussion titled “Chief Compliance Officer Perspectives: “Big Picture” Insights on Key Priorities and The Most Pressing Compliance Pain Points” on May 11 from 11:30 a.m. - 12:15 p.m. The panel will include Daryl Kreml, chief compliance officer at Sage Therapeutics, Fabiana Lacerca-Allen, senior vice president and chief compliance officer at Aimmune, and Jennifer Zerm, vice president and chief compliance officer at Fortive.